What is the address of Medibop?

The registered office of Medibop is located at Ooievaarsstraat 1 box A, 1000 Brussel.

Is Medibop still active?

Yes. According to the CBE (5 October 2026) Medibop is active, legal situation “Normale toestand”, started on 22 February 2012.

Is Medibop registered on Peppol?

Yes, Medibop is registered on the Peppol network with ID 0208:0843858725.

What is the enterprise number of Medibop?

The enterprise number of Medibop is BE0843858725.

When was Medibop founded?

Medibop was founded on 22 February 2012.

Who are the directors of Medibop?

According to the 2025 annual accounts, the directors of Medibop are: Jean-Marc BAUP.

Is Medibop a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 February 2012; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Medibop make in 2025?

Medibop posted a profit after taxes of € 49,718 in financial year 2025.

What is the revenue of Medibop?

As a small company, Medibop is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 68,862.

Medibop (Private Limited) - Brussel - BE0843858725

Dossier Medibop, printed on 5 October 2026 from databakkes.be/en/0843858725/medibop. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Medibop from Brussel, company number BE0843858725, closed financial year 2025 with a result of € 49,718 after tax. For that financial year Medibop recorded a gross margin of € 68,862 and equity of € 66,717. Compared with financial year 2024, the result moved from € 58,931 to € 49,718. The company is profitable. The buffer shrank hard: equity is 53 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 20, 2026.

What it is worth Shrank hard

€ 66,717

▼ 53% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 49,718

▼ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,767

▲ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 124,060 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 3,924

▼ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 22,213

▼ 1% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,469

▼ 80% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 100,691 Gross margin 2022: € 100,691 First fiscal year in the series	€ 90,075 Gross margin 2023: € 90,075 ▼ 11% vs 2022 (€ 100,691) Unfavourable step	€ 81,082 Gross margin 2024: € 81,082 ▼ 10% vs 2023 (€ 90,075) Unfavourable step	€ 68,862 Gross margin 2025: € 68,862 ▼ 15% vs 2024 (€ 81,082) Unfavourable step	▼ 15%
Profit after taxes	€ 67,501 Profit after taxes 2022: € 67,501 First fiscal year in the series	€ 65,135 Profit after taxes 2023: € 65,135 ▼ 4% vs 2022 (€ 67,501) Unfavourable step	€ 58,931 Profit after taxes 2024: € 58,931 ▼ 10% vs 2023 (€ 65,135) Unfavourable step	€ 49,718 Profit after taxes 2025: € 49,718 ▼ 16% vs 2024 (€ 58,931) Unfavourable step	▼ 16%
Equity	€ 84,493 Equity 2022: € 84,493 First fiscal year in the series	€ 82,128 Equity 2023: € 82,128 ▼ 3% vs 2022 (€ 84,493) Unfavourable step	€ 141,059 Equity 2024: € 141,059 ▲ 72% vs 2023 (€ 82,128) Favourable step	€ 66,717 Equity 2025: € 66,717 ▼ 53% vs 2024 (€ 141,059) Unfavourable step	▼ 53%
Total debts	€ 47,464 Total debts 2022: € 47,464 First fiscal year in the series	€ 36,524 Total debts 2023: € 36,524 ▼ 23% vs 2022 (€ 47,464) Favourable step	€ 29,688 Total debts 2024: € 29,688 ▼ 19% vs 2023 (€ 36,524) Favourable step	€ 48,494 Total debts 2025: € 48,494 ▲ 63% vs 2024 (€ 29,688) Unfavourable step	▲ 63%
Cash	€ 52,985 Cash 2022: € 52,985 First fiscal year in the series	€ 54,406 Cash 2023: € 54,406 ▲ 3% vs 2022 (€ 52,985) Favourable step	€ 30,853 Cash 2024: € 30,853 ▼ 43% vs 2023 (€ 54,406) Unfavourable step	€ 33,767 Cash 2025: € 33,767 ▲ 9% vs 2024 (€ 30,853) Favourable step	▲ 9%
Retained profit	€ 72,093 Retained profit 2022: € 72,093 First fiscal year in the series	€ 69,728 Retained profit 2023: € 69,728 ▼ 3% vs 2022 (€ 72,093) Unfavourable step	€ 128,659 Retained profit 2024: € 128,659 ▲ 85% vs 2023 (€ 69,728) Favourable step	€ 54,317 Retained profit 2025: € 54,317 ▼ 58% vs 2024 (€ 128,659) Unfavourable step	▼ 58%
Dividend	€ 55,700 Dividend 2022: € 55,700 First fiscal year in the series	€ 67,500 Dividend 2023: € 67,500 ▲ 21% vs 2022 (€ 55,700) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 67,500) Unchanged	€ 124,060 Dividend 2025: € 124,060 Unchanged (€ 0) Unchanged
Bank debt	€ 35,452 Bank debt 2022: € 35,452 First fiscal year in the series	€ 21,571 Bank debt 2023: € 21,571 ▼ 39% vs 2022 (€ 35,452) Favourable step	€ 22,347 Bank debt 2024: € 22,347 ▲ 4% vs 2023 (€ 21,571) Unfavourable step	€ 22,213 Bank debt 2025: € 22,213 ▼ 1% vs 2024 (€ 22,347) Favourable step	▼ 1%
Balance sheet total	€ 131,957 Balance sheet total 2022: € 131,957 First fiscal year in the series	€ 118,652 Balance sheet total 2023: € 118,652 ▼ 10% vs 2022 (€ 131,957) Unchanged	€ 170,748 Balance sheet total 2024: € 170,748 ▲ 44% vs 2023 (€ 118,652) Unchanged	€ 115,211 Balance sheet total 2025: € 115,211 ▼ 33% vs 2024 (€ 170,748) Unchanged	▼ 33%

Key figures of Medibop, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Medibop?

What happened at Medibop in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 20, 2026 New annual accounts for financial year 2025: profit of € 49,718 (▼ 16% vs 2024). Source: NBB ↗
Mar 1, 2012 New establishment in Brussel. KBO
Feb 22, 2012 Start of the company according to the CBE. KBO

In short

From € 67,501 profit in 2022 to € 49,718 profit in 2025.

Paid € 97,458 in corporate taxes since 2022.

Best year ever: 2022, with € 67,501 profit.

Paid out € 247,260 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Medibop? We notify you, reason included.

Follow Medibop

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit